ResApp Fundamentals & General Discussion, page-7

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 7 Last

Share
Profile

Follow
nickoffshore

182 Posts.

84

06/08/20

18:43

Post #: 46357697
Share

Originally posted by eason2946 ↑

Hi all,

Given discussion with FDA is still unknown at this stage, I believe FDA approval is not gonna be on the horizon until some time in 2021 unfortunately. Personally I think the MOU with RB is the next big thing for ResApp that's really gonna change its fundamental and it's currently under the radar. Obviously any new European telehealth partners will boost the SP as well.

After some research, I found this interesting article:

https://hbw.pharmaintelligence.info...ests-In-AI-Symptom-Checker-To-Unlock-SelfCare

It seems like RB has invested in self-care digital health sector and Your.Md is their first step. I imagine their partnership with ResAppDx is a similar strategic MOU and developing an app like Your.Md where consumers can use it to identify different respiratory conditions and provide recommendednext steps. I believe this direct to consumer approach has the largest market size and the most effect market penetration and the revenue stream will be much bigger than telehealth. We should hopefully hear an update about this by the end of the year.

Below is the info from ResApp's investor presentation back in April this year:

What's everyone thought on this?

GLTAH and DYOR.

Expand

Thanks eason2946 Refreshing to see a great post , I've Put more people on ignore in the last 4 weeks than I have in the last few years .
Yes I'm patiently waiting for an update on the RB as well , exciting times to look fwd to all round really .
Go the RAP

RAP Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
19 Upvote

0 Great analysis

Reply

Top Stories

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

AII

Inside the depths of Panasqueira: A legacy carved in rock

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

ResApp Fundamentals & General Discussion, page-7

Top Stories

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

Inside the depths of Panasqueira: A legacy carved in rock

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Rare earths stocks surge as Pentagon buys big stake in US REE miner

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Featured News